Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 551
Gene Symbol: AVP
AVP
0.350 Biomarker phenotype BEFREE The findings contribute valuable information that intranasal AVP can treat orthopedic pain after surgery, and AVP could be an option for pain relief by intranasal administration. 30082217 2019
Entrez Id: 551
Gene Symbol: AVP
AVP
0.350 Biomarker phenotype BEFREE LSMEMs demonstrate that treatment with AVP-825 is associated with lower average migraine pain intensity and disability from 10 to 90 minutes and greater within-person consistency across multiple migraine attacks (reduced WPV) from 45 to 120 minutes post-dose compared to oral sumatriptan. 31062349 2019
Entrez Id: 551
Gene Symbol: AVP
AVP
0.350 Biomarker phenotype BEFREE These results from the COMPASS study further demonstrate that treatment with AVP-825 provides earlier onset and more consistent across-episode improvement of pain and migraine-associated symptoms compared with oral sumatriptan, highlighting the clinical advantages of this newly approved intranasal delivery system for low-dose sumatriptan powder. 28497569 2017
Entrez Id: 551
Gene Symbol: AVP
AVP
0.350 Biomarker phenotype BEFREE Copeptin and cortisol were measured five times during an established model of transdermal electrical stimulation designed to assess pain and hyperalgesia. 28106611 2017
Entrez Id: 551
Gene Symbol: AVP
AVP
0.350 Biomarker phenotype BEFREE While most studies comparing treatments measure differences in proportions of patients achieving a dichotomous endpoint at fixed time intervals, in this study we compare trajectories of migraine pain and disability over time for AVP-825 versus 100 mg oral sumatriptan tablets. 28880380 2017
Entrez Id: 551
Gene Symbol: AVP
AVP
0.350 Therapeutic phenotype CTD_human Phenylephrine-induced antinociception: investigations of potential neural and endocrine bases. 2271928 1990
Entrez Id: 551
Gene Symbol: AVP
AVP
0.350 Therapeutic phenotype CTD_human Pain threshold changes in rats following central injection of beta-endorphin, met-enkephalin, vasopressin or oxytocin antisera. 6094376 1984